Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: A risk of opportunistic infection after treatment with anti-CCR4 antibodies

Annals of Hematology

Volumn 93, Issue 1, 2014, Pages 169-171

  Ohyama, Yasuyo ^a   Kumode, Takahiro ^a   Eguchi, Go ^a   Yamaguchi, Terufumi ^a   Maeda, Yasuhiro ^a  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYCLOPHOSPHAMIDE; ETOPOSIDE; GANCICLOVIR; HORSERADISH PEROXIDASE; MOGAMULIZUMAB; PIRARUBICIN; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADULT; AGED; CANCER PATIENT; CANCER SURVIVAL; CASE REPORT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG ERUPTION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; INFUSION RELATED REACTION; LETTER; LEUKEMIA REMISSION; LEUKOCYTE; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 84891879236     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1765-6     Document Type: Letter

References (11)

1. Uchiyama T, Yodoi J, Sagawa K et al (1977) Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-92 (Pubitemid 8180432)
2. Yoshida M, Miyoshi I, Hinuma Y et al (1982) Isolation and characterization of retrovirus from cell lines of human adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79:2031-5 (Pubitemid 12088563)
3. Yoshie O, Fujisawa R, Nakayama T et al (2002) Frequent expression of CCR4 in adult T cell leukemia and human T cell leukemia virus type 1-transformed T cells. Blood 99:1505-11 (Pubitemid 34533017)
4. Ishida T, Utsunomiya A, Iida S et al (2003) Clinical significance of CCR4 expression in adult T cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9:3625-34 (Pubitemid 37169227)
5. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K et al (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T cell leukemia-lymphoma and peripheral T cell lymphoma. J Clin Oncol 28:1591-8
6. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S et al (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30:837-42
7. Yano H, Ishida T, Inagaki A, Ishii T et al (2007) Regulatory T cell function of adult T cell leukemia/lymphoma cells. Int J Cancer 120:2052-7 (Pubitemid 46418388)
8. Bangham CR, Toulza F (2011) Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1. Adv Cancer Res 111:163-82
9. Wohl DA, Zeng D, Stewart P, Glomb N, Alcorn T, Jones S, Handy J, Fiscus S, Weinberg A, Gowda D, van der Horst C (2005) Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr 38:538-44 (Pubitemid 40524475)
10. Fujimoto D, Matsushima A, Nagao M, Takakura S, Ichiyama S (2013) Risk factors associated with elevated blood cytomegalovirus pp65 antigen levels in patients with autoimmune diseases. Mod Rheumatol 23(2):345-350. doi: 10.1007/s10165-012-0651-8, Epub 2012 Apr 26
11. Antoine P, Olislagers V, Huygens A, Lecomte S, Liesnard C, Donner C, Marchant A (2012) Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. J Immunol 189:2665-72